SavedAdd your journal

Journals / Gülhane Tıp Dergisi / 2015 / Cilt: 57 - Sayı: 7

Treatment of severe metabolic alkalosis in a patient with congestive heartfailure following coronary bypass surgery

Koroner arter baypas greftleme operasyonu sonrası gelişen ağır metabolik alkalozda tedavi yaklaşımı

Adem GÜLER
Hikmet SAHRATOV
Fahri Gürkan YEŞİL
Pages
446–447
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case, we aimed to discuss the treatment management of resistant metabolic alkalosis following coronary artery bypass graft surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Treatment of severe metabolic alkalosis in a patient with congestive heart failure following coronary bypass surgeryMetabolic alkalosis, defined as a primary increment in plasma bicarbonate concentration, is a common complication in hospitalized patients and is associated with high morbidity and mortality in severe cases.
📊
Key Findings & Data:Metabolic alkalosis is the most common acid base disorder in patients with congestive heart failure and it is usually associated with diuretic therapy.
💡
Conclusion & Impact:In this case, we aimed to discuss the treatment management of resistant metabolic alkalosis following coronary artery bypass graft surgery.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Treatment of severe metabolic alkalosis in a patient with congestive heart failure following coronary bypass surgeryMetabolic alkalosis, defined as a primary increment in plasma bicarbonate concentration, is a common complication in hospitalized patients and is associated with high morbidity and mortality in severe cases. Metabolic alkalosis is the most common acid base disorder in patients with congestive heart failure and it is usually associated with diuretic therapy. In this case, we aimed to discuss the treatment management of resistant metabolic alkalosis following coronary artery bypass graft surgery.

Özet

Metabolik alkaloz primer olarak plazma bikarbonat konsantrasyonunun artması ile karakterize olup, çoğunlukla hospitalize hastalara uygulanan tedavilerle birlikte görülmekte ve ciddi vakalarda yüksek morbidite ve mortalite ile ilişkilidir. Metabolik alkoloz konjestif kalp yetmezlikli vakalarda görülen en sık asit-baz bozukluğu olup, çoğu kez diüretik tedavisi ile ilişkilidir. Biz bu vakada koroner arter baypas greftleme operasyonu yapılan ve yoğun bakım takibi sırasında dirençli metabolik alkalozis gelişen hastada tedavi yaklaşımımızı sunmayı amaçladık.

🔖

Cite This Article

GÜLER, A., SAHRATOV, H., YEŞİL, F. G. (2015). Treatment of severe metabolic alkalosis in a patient with congestive heartfailure following coronary bypass surgery. Gülhane Tıp Dergisi, Cilt: 57 - Sayı: 7, 446–447. https://ajindex.com/articles/207815

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Peixoto AJ, Alpern RJ. Treatment of severe metabolic alkalosis in a patient with congestive heart failure.Am J Kidney Dis. 2013;61(5):822-7 2. Pahari DK, Kazmi W, Raman G, Biswas S. Diagnosis and management of metabolic alkalosis. J Indian Med Assoc. 2006;104(11):630-4, 636. 3. Gulsvik R, Skjørten I, Undhjem K et al. Acetazolamide improves oxygenation in patients with respiratory failure and metabolic alkalosis.Clin Respir J. 2013;7(4):390-6 4. García Martínez T, Montañés Pauls B, Reig Valero R, Roch Ventura MA, Ibáñez Benages E.[Hydrochloric acid for treatment of severe metabolic alkalosis]. Farm Hosp. 2013;37(4):337-8. 5. Khanna A, Kurtzman NA.Metabolic alkalosis. J Nephrol. 2006;19 Suppl 9:S86-96. 6. Palmer BF Metabolic complications associated with use of diuretics. Semin Nephrol. 2011;31(6):542-52.